C. Albanese, J. Hulit, and T. Sakamaki, Recent advances in inducible expression in transgenic mice, Seminars in Cell & Developmental Biology, vol.13, issue.2, pp.129-141, 2002.
DOI : 10.1016/S1084-9521(02)00021-6

N. Blake, S. Lee, and I. Redchenko, Human CD8+ T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)???Containing Protein Requires Exogenous Processing, Immunity, vol.7, issue.6, pp.791-802, 1997.
DOI : 10.1016/S1074-7613(00)80397-0

F. Carlotti, M. Bazuine, and T. Kekarainen, Lentiviral Vectors Efficiently Transduce Quiescent Mature 3T3-L1 Adipocytes, Molecular Therapy, vol.9, issue.2, pp.209-217, 2004.
DOI : 10.1016/j.ymthe.2003.11.021

D. Favre, V. Blouin, and N. Provost, Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus, Journal of Virology, vol.76, issue.22, pp.11605-11611, 2002.
DOI : 10.1128/JVI.76.22.11605-11611.2002

M. Gossen, S. Freundlieb, and G. Bender, Transcriptional activation by tetracyclines in mammalian cells, Science, vol.268, issue.5218, pp.1766-1769, 1995.
DOI : 10.1126/science.7792603

W. Hendriks, R. Eggers, and T. Carlstedt, Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune ''stealth'' transgene, Restor Neurol Neurosci, vol.25, pp.585-599, 2007.

M. Hoyt, J. Zich, and J. Takeuchi, Glycine???alanine repeats impair proper substrate unfolding by the proteasome, The EMBO Journal, vol.22, issue.8, pp.1720-1729, 2006.
DOI : 10.1038/sj.emboj.7601058

J. Karttunen, S. Sanderson, and N. Shastri, Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens., Proceedings of the National Academy of Sciences, vol.89, issue.13, pp.6020-6024, 1992.
DOI : 10.1073/pnas.89.13.6020

M. Latta-mahieu, R. M. Caillet, and C. , Gene Transfer of a Chimeric Trans-Activator Is Immunogenic and Results in Short-Lived Transgene Expression, Human Gene Therapy, vol.13, issue.13, pp.1611-1620, 2002.
DOI : 10.1089/10430340260201707

J. Levitskaya, A. Sharipo, and A. Leonchiks, Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1, Proceedings of the National Academy of Sciences, vol.94, issue.23, pp.12616-12621, 1997.
DOI : 10.1073/pnas.94.23.12616

M. Ossevoort, A. Zaldumbide, and S. Cramer, Characterization of an immuno ???stealth??? derivative of the herpes simplex virus thymidine-kinase gene, Cancer Gene Therapy, vol.199, issue.6, pp.584-591, 2006.
DOI : 10.1038/sj.cgt.7700925

A. Sharipo, M. Imreh, and A. Leonchiks, -Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition, FEBS Letters, vol.69, issue.1-2, pp.137-142, 2001.
DOI : 10.1016/S0014-5793(01)02542-X

S. Urlinger, U. Baron, and M. Thellmann, Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity, Proceedings of the National Academy of Sciences, vol.97, issue.14, pp.7963-7968, 2000.
DOI : 10.1073/pnas.130192197

Y. Yin, B. Manoury, and R. Fahraeus, Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1, Science, vol.301, issue.5638, pp.1371-1374, 2003.
DOI : 10.1126/science.1088902

A. Zaldumbide and R. Hoeben, How not to be seen: immune-evasion strategies in gene therapy, Gene Therapy, vol.114, issue.4, pp.239-246, 2008.
DOI : 10.1016/S0014-5793(01)02542-X

A. Zaldumbide, M. Ossevoort, and E. Wiertz, In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma Herpes virus, Molecular Immunology, vol.44, issue.6, pp.1352-1360, 2007.
DOI : 10.1016/j.molimm.2006.05.012